4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0001140361-16-086602
Director sold 86,270 shares at an average $11.16 ($962,907)
From the SEC's structured data for this filing
Trades in this filing
SHANNON TIMOTHY M · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-11-10 | Sale : show line 1 in the form | −27,135 | $11.07 | $300,390 | 3,903,516 | I |
| 2016-11-11 | Sale : show line 2 in the form | −35,391 | $11.20 | $396,461 | 3,868,125 | I |
| 2016-11-14 | Sale : show line 3 in the form | −23,744 | $11.21 | $266,056 | 3,844,381 | I |
| Open-market sales · 86,270 sh · avg $11.16 · $962,907 | ||||||
Loading xslF345X03/doc1.xml…